112 related articles for article (PubMed ID: 32434192)
1. Transketolase-Like Protein 1 and Glucose Transporter 1 in Gastric Cancer.
Ahopelto K; Laitinen A; Hagström J; Böckelman C; Haglund C
Oncology; 2020; 98(9):643-652. PubMed ID: 32434192
[TBL] [Abstract][Full Text] [Related]
2. Transketolase-like protein 1 expression predicts poor prognosis in colorectal cancer.
Ahopelto K; Böckelman C; Hagström J; Koskensalo S; Haglund C
Cancer Biol Ther; 2016; 17(2):163-8. PubMed ID: 26650256
[TBL] [Abstract][Full Text] [Related]
3. TKTL1 and p63 are biomarkers for the poor prognosis of gastric cancer patients.
Song Y; Liu D; He G
Cancer Biomark; 2015; 15(5):591-7. PubMed ID: 26406948
[TBL] [Abstract][Full Text] [Related]
4. Expression of transketolase-like 1 protein (TKTL1) in human endometrial cancer.
Krockenberger M; Engel JB; Schmidt M; Kohrenhagen N; Häusler SF; Dombrowski Y; Kapp M; Dietl J; Honig A
Anticancer Res; 2010 May; 30(5):1653-9. PubMed ID: 20592357
[TBL] [Abstract][Full Text] [Related]
5. TKTL1 as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma and Its Correlation with FDG-PET-CT.
Ahopelto K; Saukkonen K; Hagström J; Kauhanen S; Seppänen H; Böckelman C; Haglund C
Oncology; 2021; 99(3):177-185. PubMed ID: 33120381
[TBL] [Abstract][Full Text] [Related]
6. Expression patterns and prognostic role of transketolase-like 1 in muscle-invasive bladder cancer.
Semilia M; Hennenlotter J; Pavone C; Bischoff T; Kühs U; Gakis G; Bedke J; Stenzl A; Schwentner C; Todenhöfer T
World J Urol; 2015 Oct; 33(10):1403-9. PubMed ID: 25572961
[TBL] [Abstract][Full Text] [Related]
7. Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression.
Kayser G; Sienel W; Kubitz B; Mattern D; Stickeler E; Passlick B; Werner M; Zur Hausen A
Pathology; 2011 Dec; 43(7):719-24. PubMed ID: 22027741
[TBL] [Abstract][Full Text] [Related]
8. Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer.
Staiger WI; Coy JF; Grobholz R; Hofheinz RD; Lukan N; Post S; Schwarzbach MH; Willeke F
Oncol Rep; 2006 Oct; 16(4):657-61. PubMed ID: 16969476
[TBL] [Abstract][Full Text] [Related]
9. GLUT-1(+)/TKTL1(+) coexpression predicts poor outcome in oral squamous cell carcinoma.
Grimm M; Munz A; Teriete P; Nadtotschi T; Reinert S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):743-53. PubMed ID: 24703406
[TBL] [Abstract][Full Text] [Related]
10. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival.
Kawamura T; Kusakabe T; Sugino T; Watanabe K; Fukuda T; Nashimoto A; Honma K; Suzuki T
Cancer; 2001 Aug; 92(3):634-41. PubMed ID: 11505409
[TBL] [Abstract][Full Text] [Related]
11. TKTL1 expression and its downregulation is implicated in cell proliferation inhibition and cell cycle arrest in esophageal squamous cell carcinoma.
Shi Z; Tang Y; Li K; Fan Q
Tumour Biol; 2015 Nov; 36(11):8519-29. PubMed ID: 26032094
[TBL] [Abstract][Full Text] [Related]
12. Transketolase-like 1 expression correlates with subtypes of ovarian cancer and the presence of distant metastases.
Krockenberger M; Honig A; Rieger L; Coy JF; Sutterlin M; Kapp M; Horn E; Dietl J; Kammerer U
Int J Gynecol Cancer; 2007; 17(1):101-6. PubMed ID: 17291239
[TBL] [Abstract][Full Text] [Related]
13. Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma.
Fenske W; Völker HU; Adam P; Hahner S; Johanssen S; Wortmann S; Schmidt M; Morcos M; Müller-Hermelink HK; Allolio B; Fassnacht M
Endocr Relat Cancer; 2009 Sep; 16(3):919-28. PubMed ID: 19465749
[TBL] [Abstract][Full Text] [Related]
14. A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells.
Grimm M; Schmitt S; Teriete P; Biegner T; Stenzl A; Hennenlotter J; Muhs HJ; Munz A; Nadtotschi T; König K; Sänger J; Feyen O; Hofmann H; Reinert S; Coy JF
BMC Cancer; 2013 Dec; 13():569. PubMed ID: 24304513
[TBL] [Abstract][Full Text] [Related]
15. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted.
Langbein S; Zerilli M; Zur Hausen A; Staiger W; Rensch-Boschert K; Lukan N; Popa J; Ternullo MP; Steidler A; Weiss C; Grobholz R; Willeke F; Alken P; Stassi G; Schubert P; Coy JF
Br J Cancer; 2006 Feb; 94(4):578-85. PubMed ID: 16465194
[TBL] [Abstract][Full Text] [Related]
16. Transketolase like 1 (TKTL1) expression alterations in prostate cancer tumorigenesis.
da Costa IA; Hennenlotter J; Stühler V; Kühs U; Scharpf M; Todenhöfer T; Stenzl A; Bedke J
Urol Oncol; 2018 Oct; 36(10):472.e21-472.e27. PubMed ID: 30119993
[TBL] [Abstract][Full Text] [Related]
17. High TKTL1 expression as a sign of poor prognosis in colorectal cancer with synchronous rather than metachronous liver metastases.
Peltonen R; Ahopelto K; Hagström J; Böckelman C; Haglund C; Isoniemi H
Cancer Biol Ther; 2020 Sep; 21(9):826-831. PubMed ID: 32795237
[TBL] [Abstract][Full Text] [Related]
18. Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK.
Schmidt M; Voelker HU; Kapp M; Krockenberger M; Dietl J; Kammerer U
J Cancer Res Clin Oncol; 2010 Feb; 136(2):219-25. PubMed ID: 19655166
[TBL] [Abstract][Full Text] [Related]
19. [Expression of glucose transporter 1 in gastric carcinoma and metastatic lymph nodes and its association with prognosis].
Wei B; Chen L; Li J
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):277-80. PubMed ID: 19434538
[TBL] [Abstract][Full Text] [Related]
20. Lactate-dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1.
Kayser G; Kassem A; Sienel W; Schulte-Uentrop L; Mattern D; Aumann K; Stickeler E; Werner M; Passlick B; zur Hausen A
Diagn Pathol; 2010 Apr; 5():22. PubMed ID: 20385008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
